Research ArticleTheranostics
Side Effects of CXC-Chemokine Receptor 4–Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation
Sabine Maurer, Peter Herhaus, Romina Lippenmeyer, Heribert Hänscheid, Malte Kircher, Andreas Schirbel, H. Carlo Maurer, Andreas K. Buck, Hans-Jürgen Wester, Hermann Einsele, Götz-Ulrich Grigoleit, Ulrich Keller and Constantin Lapa
Journal of Nuclear Medicine October 2019, 60 (10) 1399-1405; DOI: https://doi.org/10.2967/jnumed.118.223420
Sabine Maurer
1III. Medical Department, Hematology and Medical Oncology, Technische Universität München, Munich, Germany
Peter Herhaus
1III. Medical Department, Hematology and Medical Oncology, Technische Universität München, Munich, Germany
Romina Lippenmeyer
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
Heribert Hänscheid
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
Malte Kircher
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
Andreas Schirbel
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
H. Carlo Maurer
3II. Medical Department, Gastroenterology and Hepatology, Technische Universtät München, Munich, Germany
Andreas K. Buck
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
Hans-Jürgen Wester
4Pharmaceutical Radiochemistry, Technische Universität München, Munich, Germany
Hermann Einsele
5Hematology and Medical Oncology, Medical Department II, University Hospital Würzburg, Würzburg, Germany; and
Götz-Ulrich Grigoleit
5Hematology and Medical Oncology, Medical Department II, University Hospital Würzburg, Würzburg, Germany; and
Ulrich Keller
1III. Medical Department, Hematology and Medical Oncology, Technische Universität München, Munich, Germany
6Hematology, Oncology, and Tumor Immunology (Campus Benjamin Franklin), Charité–Universitätsmedizin Berlin, Berlin, Germany
Constantin Lapa
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 10
October 1, 2019
Side Effects of CXC-Chemokine Receptor 4–Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation
Sabine Maurer, Peter Herhaus, Romina Lippenmeyer, Heribert Hänscheid, Malte Kircher, Andreas Schirbel, H. Carlo Maurer, Andreas K. Buck, Hans-Jürgen Wester, Hermann Einsele, Götz-Ulrich Grigoleit, Ulrich Keller, Constantin Lapa
Journal of Nuclear Medicine Oct 2019, 60 (10) 1399-1405; DOI: 10.2967/jnumed.118.223420
Side Effects of CXC-Chemokine Receptor 4–Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation
Sabine Maurer, Peter Herhaus, Romina Lippenmeyer, Heribert Hänscheid, Malte Kircher, Andreas Schirbel, H. Carlo Maurer, Andreas K. Buck, Hans-Jürgen Wester, Hermann Einsele, Götz-Ulrich Grigoleit, Ulrich Keller, Constantin Lapa
Journal of Nuclear Medicine Oct 2019, 60 (10) 1399-1405; DOI: 10.2967/jnumed.118.223420
Jump to section
Related Articles
Cited By...
- Theranostics in Hematooncology
- C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma
- Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET
- Biokinetics and Dosimetry of 177Lu-Pentixather
- CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma